Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Connor M Blair

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Biochemical Society Transactions|September 12, 2019
Reshaping cAMP nanodomains through targeted disruption of compartmentalised phosphodiesterase signalosomesConnor M Blair, George S Baillie
Expert Review of Anticancer Therapy|February 16, 2024
Exploiting c-RAF dependency in RAS mutant cancer: <i>beyond catalytic activity</i>Sean F Cooke, Connor M Blair
Bio-Protocol|March 4, 2021
Measuring cAMP Specific Phosphodiesterase Activity: A Two-step RadioassayConnor M Blair, Jiayue Ling, George S Baillie
Bio-Protocol|March 4, 2021
Fibrin Breakdown AssayJiayue Ling, Connor M Blair, George S Baillie
Cellular Signalling|April 3, 2025
Precision peptide disruptors: The next generation of targeted therapeutics in oncologyBria O'Gorman, Sean F Cooke, Connor M Blair
BMC Cancer|March 27, 2019
Targeting B-Raf inhibitor resistant melanoma with novel cell penetrating peptide disrupters of PDE8A - C-RafConnor M Blair, Nicola M Walsh, Bruce H Littman, et al.
The International Journal of Biochemistry & Cell Biology|July 27, 2023
Cancer: Phosphodiesterase type 4C (PDE4C), the forgotten subfamily as a therapeutic targetThomas A Wright, Alistair O Gemmell, Gonzalo S Tejeda, et al.
Biochimica Et Biophysica Acta. Molecular Cell Research|June 23, 2023
Structural basis of CBP/p300 recruitment by the microphthalmia-associated transcription factorAlexandra D Brown, Kathleen L Vergunst, Makenzie Branch, et al.
The International Journal of Biochemistry & Cell Biology|September 25, 2024
SUMOylation of cardiac myosin binding protein-C reduces its phosphorylation and results in impaired relaxation following treatment with isoprenalineAlice Main, Sheon Mary, Yuan Yan Sin, et al.
FEBS Letters|May 9, 2024
Beta-amyloid interacts with and activates the long-form phosphodiesterase PDE4D5 in neuronal cells to reduce cAMP availabilityYuan Yan Sin, Ryan T Cameron, Melissa Schepers, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Biochemical Society Transactions|September 12, 2019
Reshaping cAMP nanodomains through targeted disruption of compartmentalised phosphodiesterase signalosomesConnor M Blair, George S Baillie
Expert Review of Anticancer Therapy|February 16, 2024
Exploiting c-RAF dependency in RAS mutant cancer: <i>beyond catalytic activity</i>Sean F Cooke, Connor M Blair
Bio-Protocol|March 4, 2021
Measuring cAMP Specific Phosphodiesterase Activity: A Two-step RadioassayConnor M Blair, Jiayue Ling, George S Baillie
Bio-Protocol|March 4, 2021
Fibrin Breakdown AssayJiayue Ling, Connor M Blair, George S Baillie
Cellular Signalling|April 3, 2025
Precision peptide disruptors: The next generation of targeted therapeutics in oncologyBria O'Gorman, Sean F Cooke, Connor M Blair
BMC Cancer|March 27, 2019
Targeting B-Raf inhibitor resistant melanoma with novel cell penetrating peptide disrupters of PDE8A - C-RafConnor M Blair, Nicola M Walsh, Bruce H Littman, et al.
The International Journal of Biochemistry & Cell Biology|July 27, 2023
Cancer: Phosphodiesterase type 4C (PDE4C), the forgotten subfamily as a therapeutic targetThomas A Wright, Alistair O Gemmell, Gonzalo S Tejeda, et al.
Biochimica Et Biophysica Acta. Molecular Cell Research|June 23, 2023
Structural basis of CBP/p300 recruitment by the microphthalmia-associated transcription factorAlexandra D Brown, Kathleen L Vergunst, Makenzie Branch, et al.
The International Journal of Biochemistry & Cell Biology|September 25, 2024
SUMOylation of cardiac myosin binding protein-C reduces its phosphorylation and results in impaired relaxation following treatment with isoprenalineAlice Main, Sheon Mary, Yuan Yan Sin, et al.
FEBS Letters|May 9, 2024
Beta-amyloid interacts with and activates the long-form phosphodiesterase PDE4D5 in neuronal cells to reduce cAMP availabilityYuan Yan Sin, Ryan T Cameron, Melissa Schepers, et al.
Pageof 2